Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Ex Input:
Paragraph: Moncef Slaoui, a former GlaxoSmithKline executive, will lead “Operation Warp Speed,” Trump’s push to accelerate the vaccine development process for COVID-19, according to an administration official. Slaoui is to serve in a volunteer capacity, and will be assisted by Army Gen. Gustave Perna, the commander of United States Army Materiel Command. The move comes as the president and White House aides hope to produce vaccines for the coronavirus faster than what many scientists believe is realistic. The administration is aiming to have 300 million doses to distribute to Americans by the end of the year, believing a reliable vaccine is the only way to promote an economic rebound. “Operation Warp Speed” is operating largely independently of the existing White House coronavirus task force, which is also shifting its focus toward vaccine development. The initiative is being promoted by White House senior adviser Jared Kushner, and involves officials from the Defense Department and the Department of Health and Human Services. On Tuesday, Dr. Anthony Fauci, the government’s top infectious disease expert, said a vaccine would not be available by the beginning of the next academic year. “The idea of having treatments available or a vaccine to facilitate re-entry of students into the fall term would be something that would be a bit of a bridge too far,” he said, “even at the top speed we’re going.” Claim: Trump to name former pharma exec as vaccine czar.

Ex Output:
President Donald Trump is set to name a former pharmaceutical executive to lead his administration’s all-out effort to produce and distribute a coronavirus vaccine by the end of the year.


Ex Input:
Paragraph: Tuesday is the final day of Sexually Transmitted Disease Awareness Month, and the state CDC says it’s recommending prevention, screening and treatment. The agency says Maine has seen “dramatic increases” in gonorrhea and syphilis in the last five years. Gonorrhea cases increased nearly 200 percent, to 686, from 2014 to 2018. Syphilis cases have risen by almost 600 percent, to 104, in that same timeframe. Acting Maine CDC Director Nancy Beardsley says the health consequences of sexually transmitted infections are serious enough that residents “know the facts about STDs and get tested if they believe they are at risk.” Claim: Maine stresses test as sexually transmitted infections surge.

Ex Output:
The Maine Center for Disease Control and Prevention is calling on residents to get tested for sexually transmitted infections amid a spike in cases of gonorrhea and syphilis in the state.


Ex Input:
Paragraph: "The story says that the average copayment for a month’s supply of some of the topical NSAID medications is around $30. It would have been nice to include the cost of comparable oral medications. Although the story explains the available evidence comparing topical NSAIDs to oral pain relievers, highlights the limited number of direct comparisons, and carefully states the general consensus of experts, all of this solid reporting is undermined by a focus on personal anecdotal evidence over quantifiable benefits. Indeed, the reporter claims one medication provided immediate relief, a statement at odds with clinical trials that conclude that it usually takes hours for patients to feel the pain-relief effects of topical NSAIDs. The story summarizes the reported side effects of topical NSAIDS. What’s more, the reporter points out that the potential risks in people who have other health problems or are taking other drugs have not been well studied. That insight is something we see too rarely. The story refers to a number of clinical trials and systematic reviews of the evidence. It highlights areas where evidence is lacking or inconclusive. It would have been helpful to point out that in placebo-controlled trials, almost as many people who received the placebo reported pain relief as did those who got the active medication. The story could have mentioned that the systematic review it referred to was published by the Cochrane Collaboration and also the sources of the other clinical trial reports, so that interested readers could more easily locate the original articles. The story does not exaggerate the common pains these drugs are intended to treat, but the personal anecdotes and opinions highlighted at the beginning and ending of the story are unrepresentative of the typical experiences reported by participants in clinical trials and create a powerful impression that is at odds with the evidence. The story includes quotes from several experts and points out that two of them have accepted consulting fees or research support from pharmaceutical companies. The essence of this story is an attempt to compare topical NSAIDs with pills and other pain treatments. As noted above, though, the story does not mention that most people with minor pains feel better after awhile even if they don’t take any pain relief medication. It also should have mentioned that the difference between placebo and active treatment groups in the clinical trials is often slim. The story reports that only three topical NSAIDs (nonsteroidal anti-inflammatory drugs) are approved for sale with a prescription in the United States, while several brands are sold over the counter in Europe. Part of the focus of the story is that NSAIDS have been around for a long time but only recently are being given a more serious scientific reassessment. As the story says, ""But a number of new controlled trials and meta-analyses like Dr. Moore’s suggest that topical Nsaids are as effective as their oral counterparts for treating osteoarthritis in the knee and hand as well as musculoskeletal injuries like soreness and tendinitis."" The story includes several experts and mentions multiple studies." Claim: Topical Gel Catches Up With Pills for Relief

Ex Output:

This story about topical gels that contain pain relief medication similar to ibuprofen makes a strong showing when examined point-by-point. Nevertheless, readers may end up with a skewed impression because of the personal anecdote and opinion that open and close the story. The headline and lead, as well as the last words of a story, can carry a lot of weight. The meat of the story includes a comprehensive overview of the medical evidence, but then there are phrases such as, “She raved about the stuff” and “for immediate relief of my tennis-related muscle pull, the cream was handy and helpful.” All the careful statements of fact in the body of the story may well be drowned out by the personal comments.